Literature DB >> 3175049

Radiation tolerance of the rat rectum to fractionated X-rays and pi-mesons.

A J van der Kogel1, K A Jarrett, M A Paciotti, M R Raju.   

Abstract

A 2.5 cm segment of the rectum of female F344 rats was irradiated with up to 10 fractions of X-rays or pions. Transient signs of acute proctitis were followed by chronic rectal injury starting at about 2 months. Recto-vaginal fistulas were frequently observed in animals with severe chronic injury. Two patterns of chronic injury were observed, an early type consisting of deep ulcers and fistulas, and a late type characterized by vascular injury, fibrosis and mucosal cysts. In a 4-fraction X-ray experiment, the influence of a low-residue diet was compared with a regular diet, showing no significant differences in pathology or survival. Isoeffective doses were determined for the occurrence of severe rectal injury at 250 days. Fitting the data to an LQ-model yielded an alpha/beta ratio of 13 Gy for pions, and 6.5 Gy for X-rays. Increasing the overall treatment time from 9 days to one month gave a significant rise in isoeffective doses for chronic injury. This suggests that the more delayed types of injury did not develop independently from the acute mucosal changes. The RBE of pions for rectal injury at 250 days was 1.2 for single doses, increasing to about 1.4-1.5 at a dose per fraction of 4 Gy. These values are similar to those obtained in other acute and late responding tissues.

Entities:  

Mesh:

Year:  1988        PMID: 3175049     DOI: 10.1016/0167-8140(88)90265-4

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

Review 1.  Current status of intensity-modulated radiation therapy (IMRT).

Authors:  Kazuo Hatano; Hitoshi Araki; Mitsuhiro Sakai; Takashi Kodama; Naoki Tohyama; Tohru Kawachi; Masaharu Imazeki; Takayuki Shimizu; Tsutomu Iwase; Minoru Shinozuka; Hideyo Ishigaki
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

2.  Estimation of α/β for late rectal toxicity based on RTOG 94-06.

Authors:  Susan L Tucker; Howard D Thames; Jeff M Michalski; Walter R Bosch; Radhe Mohan; Kathryn Winter; James D Cox; James A Purdy; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-04       Impact factor: 7.038

3.  Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.

Authors:  Alan Pollack; Alexandra L Hanlon; Eric M Horwitz; Steven J Feigenberg; Andre A Konski; Benjamin Movsas; Richard E Greenberg; Robert G Uzzo; C-M Charlie Ma; Shawn W McNeeley; Mark K Buyyounouski; Robert A Price
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-19       Impact factor: 7.038

Review 4.  Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials.

Authors:  Víctor Macías; Albert Biete
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

5.  Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens.

Authors:  H Sudahar; P G G Kurup; V Murali; P Mahadev; J Velmurugan
Journal:  J Med Phys       Date:  2012-04

6.  Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study.

Authors:  Sara Junius; Karin Haustermans; Barbara Bussels; Raymond Oyen; Bianca Vanstraelen; Tom Depuydt; Jan Verstraete; Steven Joniau; Hendrik Van Poppel
Journal:  Radiat Oncol       Date:  2007-08-08       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.